Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Cerebrovascular Diseases(Electronic Edition) ›› 2020, Vol. 14 ›› Issue (03): 129-132. doi: 10.11817/j.issn.1673-9248.2020.03.002

Special Issue:

• Expert Forum • Previous Articles     Next Articles

Clinical research status and progress on cerebral hyperperfusion syndrome after carotid stenting

Dongpo Yao1, Zhongrong Miao2,()   

  1. 1. Department of Interventional Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China, Department of Neurology, Beijing Chaoyang Integrative Medicine Emergency Medical Center, Beijing 100122, China
    2. Department of Interventional Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
  • Received:2020-03-19 Online:2020-06-01 Published:2020-06-01
  • Contact: Zhongrong Miao
  • About author:
    Corresponding author: Miao Zhongrong, Email:

Abstract:

Symptomatic carotid stenosis is a major cause of stroke, and carotid artery stenting (CAS) has been widely used in clinical practice. Cerebral hyperperfusion syndrome (CHS) is a severe complication post CAS. This review covers the current status and progress of CHS after CAS, including the epidemiology, pathogenesis, risk factors, clinical manifestations, assistant examination, diagnosis, prevention, and treatment, in order to guide clinical practice.

Key words: Carotid stenosis, Carotid artery stenting, Hyperfusion syndrome, Research status, Progress

京ICP 备07035254号-20
Copyright © Chinese Journal of Cerebrovascular Diseases(Electronic Edition), All Rights Reserved.
Tel: 01082266456, 15611963912, 15611963911 E-mail: zhnxgbzzbysy@163.com
Powered by Beijing Magtech Co. Ltd